Mass Balance Recovery, Metabolite profile and Metabolite Identification of [14C]NXL104

Study identifier:D4280C00008

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Open Label Single-Dose Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite profile and Metabolite Identification of [14C]NXL104

Medical condition

Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

[14C]NXL104

Sex

Male

Actual Enrollment

6

Study type

Interventional

Age

30 Years - 65 Years

Date

Study Start Date: 01 Oct 2011
Primary Completion Date: 01 Nov 2011
Study Completion Date: 01 Nov 2011

Study design

Allocation: Non-randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Jul 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria